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Background: Mild elevation in tricuspid regurgitation velocity (TRV) have been reported in children with sickle cell disease (SCD), but the clinical 
implications are not known.
Methods: Children with SCD and age and gender matched controls were prospectively enrolled in a multi-center study. SCD subjects were 
reassessed two years later. Each subject underwent echocardiography (echo), hematologic testing, and 6-minute walk (6MW). Echo variables were 
compared from both visits with paired t-test and used to predict a decline in the 6MW by linear regression analysis with robust standard error 
estimate.
Results: 6MW data were available in 155 of 220 SCD subjects undergoing baseline and follow-up evaluation. Median age at initial visit was 13 
years (range 9 -16 years) and median follow up time was 21.5 months. There were no significant changes in TRV, left ventricular diastolic dimension 
z-score (LVDDz), mitral valve E/E’, blood pressure, and hemoglobin from baseline. No variable alone predicted a decline in 6MW. However, subjects 
who had a combination of an elevated TRV (>2.6 m/sec as defined by 95% in control population) and LVDDz (>2) at the initial visit had a significant 
decrease in their 6MW (table). This difference was still observed after controlling for height and hemoglobin.
Six Minute Walk Change with Tricuspid Regurgitation and LV z-score
TRV >2.6m/sec LVDD z score>2 6-minute walk change(meters)
6-minute walk 
change(height 
adjusted)
6-minute walk 
change(height and 
hemoglobin adjusted)
N
No No +4 +7 +9 101
No Yes +3 (0.9) +9 (0.9) +8 (0.9) 36
Yes No +5 (0.9) +7 (0.9) +3 (0.7) 13
Yes Yes -56 (0.049) -60 (0.020) -63 (0.017) 5
p value (compared to row 1) in parenthesis
Conclusions: The combination of elevated TRV and LVDDz predicts declining 6MW performance in children with SCD. This subset of patients with 
both mild pulmonary hypertension and volume overload may be at increased risk for morbidity.
